Tessera Therapeutics’ $230 million Series B Financing Round

Goodwin Procter LLP advised Tessera Therapeutics on the deal.Tessera Therapeutics, an early-stage life sciences company founded by Flagship Pioneering, announced today that it has raised over…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Martina Bellini

Author: Martina Bellini

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here